Critical Care Medicine Ward 1

The Department of Critical Care Medicine of the Second Affiliated Hospital of Harbin Medical University was established in 1981, and its predecessor was the Cardiac Surgery ICU. In 2003, it was expanded to 2 ward areas, in 2008 to 3 wards, and in 2013 to 4 wards, with a total of 80 beds, 58 beds actually open, and a usable area of nearly 6000 square meters. In 2010, it became one of the first National Key Clinical Specialties of the National Health and Family Planning Commission; in 2012, it was rated a key discipline of Heilongjiang Province and was the main responsible institution for projects funded by the Ministry of Health's special industry fund. In 2017, it was selected for the National Project for Enhancing the Diagnosis and Treatment Capacity for Difficult and Rare Diseases. In the same year, it was rated a pilot institution for standardized training of national critical care medicine specialists. In 2019, the Heilongjiang Province Critical Care Medicine Alliance was established, and in 2020, it was rated one of the first standardized training bases for extracorporeal life support of the Extracorporeal Life Support Professional Committee of the Chinese Medical Doctor Association. It is now the institution serving as the Heilongjiang Provincial Chair of the Critical Care Medicine Branch of the Chinese Medical Association, the institution serving as the Chair of Critical Care Nursing in Heilongjiang Province, the leading institution of the critical care medicine medical consortium in Heilongjiang Province, and the institution serving as a Standing Committee Member and Deputy Chair of the Youth Committee of the Extracorporeal Life Support Professional Committee of the Chinese Medical Doctor Association.

At present, Critical Care Ward 1 has 22 beds. There are currently 55 medical and nursing staff members in total, including 12 physicians, 5 with doctoral degrees, and 7 with master's degrees. There are 2 doctoral supervisors, 2 master's supervisors, 3 staff members with senior professional titles, and 5 with associate senior titles. The department has a highly educated, young, professionally competent, vigorous and dynamic medical and nursing team. At the same time, the department is fully equipped and is currently one of the very few critical care medicine departments in China able to independently perform advanced organ support technologies such as ECMO, IABP, and CPB, as well as core technologies such as fiberoptic bronchoscopy and PICCO, Swan-Ganz, and Vigileo hemodynamic monitoring. It has played an important role in the rescue of patients with difficult acute and critical illnesses and in emergency response to public health emergencies. The department has established an ECMO team, a respiratory therapy team, a nutrition therapy team, and others, enabling medical and nursing personnel to maximize the improvement and application of their professional technical capabilities, while also greatly promoting the overall improvement of the department's professional and technical level and providing patients with more professional medical services. In blood purification, this department is one of the earliest medical institutions in China able to carry it out independently. It can currently perform multiple CPB treatment modalities, including hemofiltration, plasma exchange, hemoadsorption, and others. In recent years, it has taken the lead in Heilongjiang Province in carrying out various blood purification technologies, including bilirubin adsorption, inflammatory factor adsorption, perfusion adsorption, DPMAS (Double Plasma Molecular Adsorption System), and the Molecular Adsorbent Recirculating System (MARS); it is the earliest institution in the province to carry out adsorption technology and the institution with the largest number of applications. Adsorption technology has been widely and skillfully applied to rescue critically ill patients with various forms of organ dysfunction, including patients with severe pneumonia, liver failure, severe acute pancreatitis, septic shock, and others. It also has experience in combined use with ECMO technology, improving the success rate of treatment for critically ill patients.